IDEXX Labs (IDXX) Tops Q1 EPS by 1c; Boosts FY12 EPS Outlook
IDEXX Labs (NASDAQ: IDXX) reported Q1 EPS of $0.72, $0.01 better than the analyst estimate of $0.71. Revenue for the quarter came in at $322.7 million versus the consensus estimate of $314.23 million.
IDEXX Labs sees FY2012 EPS of $3.07-$3.12, versus prior guidance of $3.04-$3.10 and the consensus of $3.08. IDEXX Labs sees FY2012 revenue of $1.31-$1.32 million.
For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.
IDEXX Labs sees FY2012 EPS of $3.07-$3.12, versus prior guidance of $3.04-$3.10 and the consensus of $3.08. IDEXX Labs sees FY2012 revenue of $1.31-$1.32 million.
For earnings history and earnings-related data on IDEXX Labs (IDXX) click here.